Shandong Buchang Pharmaceuticals Co.,Ltd.’s Net Profit Dropped 32.1% in First Three Quarters of 2023

Shandong Buchang Pharmaceuticals Co.,Ltd. (山东步长制药股份有限公司) (603858.SH) reported a net profit of 831.2 million yuan in the first three quarters of 2023, down 32.1% year-on-year.

Meanwhile, the company posted 10 billion yuan in revenue, down 11.7% year-on-year.

At the end of the reporting period, it had 20.6 billion yuan in total assets and 8.6 billion yuan in total liabilities, with a liability-to-asset ratio of 41.5%.